Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC boosted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 23.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,593 shares of the company's stock after purchasing an additional 3,177 shares during the quarter. Kestra Private Wealth Services LLC's holdings in Cardinal Health were worth $1,962,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of CAH. Eastern Bank purchased a new stake in shares of Cardinal Health in the third quarter worth $25,000. Frazier Financial Advisors LLC boosted its position in Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after purchasing an additional 104 shares during the last quarter. Hara Capital LLC purchased a new position in Cardinal Health in the third quarter worth about $31,000. AM Squared Ltd bought a new position in shares of Cardinal Health in the third quarter worth about $33,000. Finally, Carolina Wealth Advisors LLC bought a new position in shares of Cardinal Health in the third quarter worth about $47,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently issued reports on CAH. UBS Group lifted their target price on Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a research note on Monday, November 4th. Citigroup lifted their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a report on Friday, January 10th. Morgan Stanley boosted their price objective on Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a report on Friday, January 31st. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Finally, Barclays boosted their price target on Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus price target of $136.87.

Cardinal Health Price Performance

Shares of NYSE:CAH traded down $0.44 during midday trading on Friday, hitting $126.35. The company had a trading volume of 1,620,302 shares, compared to its average volume of 2,327,426. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The stock has a market cap of $30.52 billion, a price-to-earnings ratio of 23.57, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. The business's 50-day simple moving average is $122.85 and its 200-day simple moving average is $116.30.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's payout ratio is currently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.